Hims & Hers Health has undeniably captured market attention and investor enthusiasm, fueled by a successful Super Bowl ad campaign and its strategic entry into the high-demand GLP-1 weight loss ...

Hims & Hers Health (HIMS) stock moves a notch higher Monday morning after the company's weight-loss drug ad played during the Super Bowl. The commercial's airing raised concerns from health ...

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

The minute-long ad from telehealth company Hims & Hers shows imagery including a scale, food including pies and cheeseburgers, and a refrigerator full of vials of Hims & Hers-labeled medications ...

It took an eagle eye to spot that disclaimer on the Hims & Hers ad, however, as it was printed in small white font on a gray background. The ad also did not follow a practice required for FDA ...

The “Check before you inject” ad specifically calls out compounded medications, which is the type that Hims & Hers manufactures and is not FDA approved. Novo Nordisk blasted its telehealth ...

Earlier in February, Hims & Hers Health rallied as it was set to debut its controversial Super Bowl ad, where it positioned itself as the “affordable, doctor-trusted, formulated in the US ...

Hims & Hers Health (HIMS) stock hit a new all-time high on Thursday as retail investors have taken interest in the telehealth company. A big part of that is related to its Super Bowl LIX ad ...

Hims & Hers revealed that it will make its Big Game debut with a minute-long ad highlighting its compounded GLP-1 weight loss drug offerings. Set to Childish Gambino’s 2018 hit song “This Is America,” ...

Weirdness for weirdness' sake can be an effective tool for getting people to remember an ad. But not always for the best reasons. "Coffee-Mate tried to be weird ... the message Hims & Hers tried ...

(Hims & Hers Health) Telehealth provider Hims & Hers Health is defending its Super Bowl ad, which is styled as a political manifesto against weight-loss treatments priced “for profits ...

The ad featured a montage of junk food, abdominal fat, as well as statistics about the health risks of obesity and big pharmaceutical firms’ hefty prices. HIMS’ ad then promoted its weight ...